These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38599922)

  • 41. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Hamaguchi Y; Hasegawa M; Fujimoto M; Matsushita T; Komura K; Kaji K; Kondo M; Nishijima C; Hayakawa I; Ogawa F; Kuwana M; Takehara K; Sato S
    Br J Dermatol; 2008 Mar; 158(3):487-95. PubMed ID: 18205876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-carbamylated protein antibodies in systemic sclerosis.
    Liem SIE; Hoekstra EM; Levarht EWN; Dorjee AL; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK; Fehres CM
    Arthritis Res Ther; 2023 Jul; 25(1):123. PubMed ID: 37480150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of simple hematological parameters with disease manifestations, activity, and severity in patients with systemic sclerosis.
    Yayla ME; İlgen U; Okatan İE; UsluYurteri E; Torgutalp M; Keleşoğlu Dinçer AB; Aydemir Gülöksüz EG; Sezer S; Turgay TM; Kınıklı G; Ateş A
    Clin Rheumatol; 2020 Jan; 39(1):77-83. PubMed ID: 31317426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
    Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
    Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical database.
    Morgan ND; Shah AA; Mayes MD; Domsic RT; Medsger TA; Steen VD; Varga J; Carns M; Ramos PS; Silver RM; Schiopu E; Khanna D; Hsu V; Gordon JK; Gladue H; Saketkoo LA; Criswell LA; Derk CT; Trojanowski MA; Shanmugam VK; Chung L; Valenzuela A; Jan R; Goldberg A; Remmers EF; Kastner DL; Wigley FM; Gourh P; Boin F
    Medicine (Baltimore); 2017 Dec; 96(51):e8980. PubMed ID: 29390428
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
    Mierau R; Genth E
    Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort.
    Lazzaroni MG; Marasco E; Campochiaro C; DeVries-Bouwstra J; Gonzalez-Perez MI; Rojas-Serrano J; Hachulla E; Zanatta E; Barsotti S; Furini F; Triantafyllias K; Abignano G; Truchetet ME; De Luca G; De Langhe E; Hesselstrand R; Ingegnoli F; Bertoldo E; Smith V; Bellando-Randone S; Poormoghim H; Colombo E; Ceribelli A; Furloni A; Zingarelli S; Cavazzana I; Franceschini F; Del Galdo F; Denton CP; Cavagna L; Distler O; Allanore Y; Airò P;
    Rheumatology (Oxford); 2021 Nov; 60(11):5028-5041. PubMed ID: 33580257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis.
    Kuwana M; Kaburaki J; Okano Y; Tojo T; Homma M
    Arthritis Rheum; 1994 Jan; 37(1):75-83. PubMed ID: 8129766
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a novel particle-based multi-analyte technology for the detection of anti-fibrillarin antibodies.
    Mahler M; Kim G; Roup F; Bentow C; Fabien N; Goncalves D; Palterer B; Fritzler MJ; Villalta D
    Immunol Res; 2021 Jun; 69(3):239-248. PubMed ID: 33913080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of anti-RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis.
    Saigusa R; Asano Y; Nakamura K; Miura S; Ichimura Y; Takahashi T; Toyama T; Taniguchi T; Noda S; Aozasa N; Akamata K; Sumida H; Miyazaki M; Tamaki Z; Yanaba K; Kuwano Y; Sato S
    J Dermatol; 2015 May; 42(5):524-7. PubMed ID: 25720827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
    Shah AA; Rosen A; Hummers L; Wigley F; Casciola-Rosen L
    Arthritis Rheum; 2010 Sep; 62(9):2787-95. PubMed ID: 20506513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.
    Harvey G; Black C; Maddison P; McHugh N
    J Rheumatol; 1997 Mar; 24(3):477-84. PubMed ID: 9058652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
    Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
    Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Autoantibodies in systemic sclerosis and their clinical correlation in patients from a Midwestern region of Brazil].
    Coelho Horimoto AM; da Costa IP
    Rev Bras Reumatol; 2015; 55(3):229-39. PubMed ID: 25559063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous Features, Autoantibody Profile, and Nailfold Capillaroscopy of Systemic Sclerosis: A Study of 60 Cases.
    Dave J; Mahajan S; Khadilkar P; Pradhan V
    J Assoc Physicians India; 2022 Nov; 70(11):11-12. PubMed ID: 37355940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.
    Ghrénassia E; Avouac J; Khanna D; Derk CT; Distler O; Suliman YA; Airo P; Carreira PE; Foti R; Granel B; Berezne A; Cabane J; Ingegnoli F; Rosato E; Caramaschi P; Hesselstrand R; Walker UA; Alegre-Sancho JJ; Zarrouk V; Agard C; Riccieri V; Schiopu E; Gladue H; Steen VD; Allanore Y
    J Rheumatol; 2014 Jan; 41(1):99-105. PubMed ID: 24293584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical features of patients with connective tissue disease with anti-human upstream binding factor antibodies: A single-center retrospective study.
    Fushida N; Horii M; Fujii K; Mizumaki K; Kitano T; Sawada K; Numata N; Oishi K; Maeda S; Hamaguchi Y; Watanabe S; Matsushita T
    J Dermatol; 2024 May; 51(5):704-713. PubMed ID: 38421809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.